ImExHS Limited (AU:IME) has released an update.
ImExHS Limited reports a robust Q1 in 2024 with a 76% jump in revenue to $7.0m, bolstered by significant software contract renewals and new deals, including a $790,000 contract in Colombia. The company’s commitment to advancing its cloud-based medical imaging software is underscored by a 33% increase in annualized recurring revenue, reaching $27.0m. Despite a strong quarter, cash reserves saw a decrease, attributed to the aggressive pursuit of growth which is expected to yield higher cash receipts in the following quarter.
For further insights into AU:IME stock, check out TipRanks’ Stock Analysis page.